Showing 1000 – 1010 of 1159 results
-
Torrid Holdings Inc Initiation
William Blair initiated research coverage of Torrid Holdings Inc. (CURV $22.73). Torrid is a fast-growing, omnichannel retailer of apparel, intimates, and accessories dedicated to plus-size women, offering mostly exclusive brands and in-house designs with a particular focus on fit.
-
Arcellx Inc Initiation of Research Coverage
William Blair initiated research coverage of Arcellx, Inc. (ACLX $16.97), a clinical-stage company focused on the development and commercialization of first-in-class adaptive immune cell therapies that can be readily activated and reprogrammed.
-
Forge Global Holdings Inc Initiation
William Blair initiated research coverage of Forge Global Holdings, Inc. (FRGE $3.27), a leading financial technology company that provides critical infrastructure, data services, and technology solutions to transact in the private markets.
-
Zevra Therapeutics Inc Initiation
William Blair initiated research coverage of Zevra Therapeutics, Inc. (ZVRA $6.10), a rare-disease therapeutics company.
-
Qualys Inc Initiation
William Blair initiated research coverage of Qualys, Inc. (QLYS $126.80), a leading provider of cloud-based cybersecurity and compliance solutions that help companies identify security risks, maintain compliance with industry standards, and remediate security vulnerabilities.
-
TheRealReal Inc Initiation
William Blair initiated research coverage of TheRealReal, Inc. (REAL $14.26), an online marketplace for consigned luxury goods.
-
Lessons From 11 Years of Restaurant Industry Data
Sharon Zackfia, head of consumer research at William Blair, shares insights from over a decade of Glassdoor data to reveal how culture, leadership, and operational models—not just pay—shape employee satisfaction and long-term brand success in the restaurant sector.
-
William Blair Biotech Equity Research Head Discusses Outlook for COVID-19 Vaccines
Tim Lugo discusses unprecedent efforts of vaccine development.
-
Wingstop Inc Initiation
William Blair initiated research coverage of Wingstop Inc. (WING $325.40), the world’s largest wings-focused chicken restaurant chain.
-
Insmed Incorporated Initiation
William Blair initiated research coverage of Insmed Incorporated (INSM $127.27), a biopharmaceutical company focused on developing life-altering therapies for underserved patient populations.